-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DnptY8g225JsxX3Gj4WhKKRCuswYPOC+ptlq9f/IKwaOMoMMqKnD3BsFP4Fy5uyt MFx79XwfL8JMogYiSyHIHQ== 0000950103-97-000182.txt : 19970327 0000950103-97-000182.hdr.sgml : 19970327 ACCESSION NUMBER: 0000950103-97-000182 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 19970321 ITEM INFORMATION: Other events FILED AS OF DATE: 19970326 SROS: NONE FILER: COMPANY DATA: COMPANY CONFORMED NAME: CVS CORP CENTRAL INDEX KEY: 0000064803 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 050494040 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-01011 FILM NUMBER: 97563995 BUSINESS ADDRESS: STREET 1: ONE THEALL ROAD CITY: RYE STATE: NY ZIP: 10580 BUSINESS PHONE: 9149254000 MAIL ADDRESS: STREET 1: ONE THEALL ROAD CITY: RYE STATE: NY ZIP: 10580 FORMER COMPANY: FORMER CONFORMED NAME: MELVILLE CORP DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: MELVILLE SHOE CORP DATE OF NAME CHANGE: 19760630 8-K 1 =============================================================================== SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Agreement of 1934 Date of Report (Date of earliest event reported): March 21, 1997 CVS CORPORATION ----------------------------------------------------- (Exact Name of Registrant as Specified in its Charter) Delaware 1-1011 05-0494040 - ---------------------------------------------- ------------------------- ---------------------------------- (State or Other Jurisdiction of (Commission File Number) (IRS Employer Identification No.) Incorporation)
One CVS Drive Woonsocket, Rhode Island 02895 - ----------------------------------------------- ------------------- (Address of Principal Executive Offices) (Zip Code) (401) 765-1500 --------------------------------------------------- (Registrant's telephone number, including area code) ------------------------------------------------------------ (Former Name or Former Address, if Changed Since Last Report) =============================================================================== ITEM 5.Other Events. On March 21, 1997, CVS Corporation, a Delaware corporation ("CVS"), and Revco D.S., Inc., a Delaware corporation ("Revco"), received a request from the Federal Trade Commission for additional information relating to CVS' proposed acquisition of Revco. A press release announcing such request was issued on March 21, 1997. The information contained in the press release is incorporated herein by reference. The press release is attached hereto as Exhibit 99.1. ITEM 7(c). Exhibits. Exhibit 99.1 Press Release dated March 21, 1997. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CVS CORPORATION Dated: March 21, 1997 By: /s/ Charles Conaway ----------------------------- Name:Charles Conaway Title:Chief Financial Officer INDEX TO EXHIBITS Sequential Exhibit No. Description Page No. - ----------- ----------- ---------- Exhibit 99.1 Press Release dated March 21, 1997. EX-99.1 2 EXHIBIT 99.1 Contacts: Nancy Christal/Fred McGrail CVS Corporation (914) 722-4704 (401) 765-1500 Ext. 4630 Jim Fingeroth/Wendi Kopsick Kekst and Company (212) 593-2655 FOR IMMEDIATE RELEASE --------------------- WOONSOCKET, RI, March 21, 1997 -- CVS Corp. (NYSE: CVS) today announced that it and Revco D.S., Inc. (NYSE: RXR) have received a request for additional information from the Federal Trade Commission relating to CVS' proposed acquisition of Revco. The parties intend to respond promptly and do not expect the request to delay completion of the transaction by mid-year 1997. On February 7, 1997, CVS announced it had signed a definitive agreement providing for the combination of CVS and Revco in a stock transaction valued at approximately $2.8 billion, plus the assumption of approximately $900 million of Revco debt. Revco, with 1996 annual sales of approximately $5.1 billion, operates nearly 2,600 stores in 17 midwestern, southeastern and eastern states. CVS, with annual sales of $5.5 billion in 1996, is a leading drug store chain in the northeast and middle atlantic regions. As of February 22, 1997, CVS operated 1,417 stores in 14 states and the District of Columbia. -----END PRIVACY-ENHANCED MESSAGE-----